The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prediction of individual tamoxifen activation in breast cancer patients.
Milena Gusella
No relevant relationships to disclose
Laura Bertolaso
No relevant relationships to disclose
Anna Paola Fraccon
No relevant relationships to disclose
Carmen Barile
No relevant relationships to disclose
Anna Rizzi
No relevant relationships to disclose
Sabrina Carturan
No relevant relationships to disclose
Caterina Modonesi
No relevant relationships to disclose
Cristina Ghiotto
No relevant relationships to disclose
Giorgio Crepaldi
No relevant relationships to disclose
Marta Mion
No relevant relationships to disclose
Romana Segati
No relevant relationships to disclose
Robeto Padrini
No relevant relationships to disclose
Silvia Toso
No relevant relationships to disclose
Marta Zaninelli
No relevant relationships to disclose
Monica Ramello
No relevant relationships to disclose
Ottaviano Tomassi
No relevant relationships to disclose
Marcello Magazu'
No relevant relationships to disclose
Nadia Minicuci
No relevant relationships to disclose
Franco Bassan
No relevant relationships to disclose
Felice Pasini
No relevant relationships to disclose